Private equity eyes Pacific Smiles as EGM looms
SURFERS PARADISE: Private equity firms Crescent Capital and BGH Capital are expected to ... read more
BiomeBank has raised $10.7m to fast-track Crohn’s disease treatment
ADELAIDE: BiomeBank has raised $10.65m with the Adelaide-based biotechnology company to use the ... read more
Cochlear acquisition deal sparks ACCC competition concerns
MELBOURNE: Cochlear’s proposed $170 million acquisition of a Danish hearing loss device maker ... read more